NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/10/2026
Back to search
Official data from USPTO
NMDP BIOTHERAPIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
NMDP BIOTHERAPIES
ST13
US500000098152034Class
1, 5, 35, 41, 42
Filing
98152034
Registration
8170229
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
03/11/2026
Trademark type
Word
Nice classes
1, 5, 35, 41, 42
Filing date
08/26/2023
Registration date
03/10/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2026
Last transaction
03/11/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2024-01-00
First use in commerce
2024-01-00
Drawing code
4
Owner type
54
Owner location
Minneapolis, MN, US
Examiner
BURCH, JILLIAN RENEE
Law office
O10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
N. P. (pessoa física)
Representatives
Kourtney A. Mulcahy AKERMAN LLP
Technical classification
Nice Classes
Class 1Class 5Class 35Class 41Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Biological tissuebone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for scientific research usefor developing new cellular therapies and other treatments
Class 5
Biological tissuebone marrow and peripheral blood stem cells of consented donors of bone marrow and blood stem cells for medical purposes
Class 35
Logistics management in the medical fieldmanagement and coordination of medical services related to bone marrow and stem cell donation; Transportation logistics servicesarranging for the transportation of goods for othersparticularly of products and samples from a collection site to entities who are developing new cellular therapies and other treatments related to bone marrow and peripheral blood stem cells
Class 41
educational and training servicesproviding seminarsworkshopsconferencesclasseslectures and presentations in the field of stem cellsstem cell research and stem cell applications and cellular therapies and distribution of course and educational materials in connection therewith
Class 42
providing medical research services for developing new cellular therapies and other treatments in the field of bone marrow and peripheral blood stem cells
Publications
History of USPTO decisions and trademark events.
33 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/19/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/19/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2026
ALIE
ASSIGNED TO LIE
02/19/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/10/2026
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
11/07/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
11/07/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/11/2025
GNRT
NON-FINAL ACTION E-MAILED
08/11/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
08/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/28/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/28/2025
IUAF
USE AMENDMENT FILED
03/26/2025
EISU
TEAS STATEMENT OF USE RECEIVED
03/26/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/02/2024
EX1G
SOU EXTENSION 1 GRANTED
10/02/2024
EXT1
SOU EXTENSION 1 FILED
10/02/2024
EEXT
SOU TEAS EXTENSION RECEIVED
10/02/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/06/2024
PUBO
PUBLISHED FOR OPPOSITION
02/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/17/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/28/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
12/28/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/28/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
12/28/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/28/2023
DOCK
ASSIGNED TO EXAMINER
12/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/26/2023
NWAP
NEW APPLICATION ENTERED
08/30/2023
Continuous trademark protection
Get notified about every new filing that threatens NMDP BIOTHERAPIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.